scanX
Home
Pfizer

Pfizer

4,377.00
-48.80
(-1.10%)
Market Cap
20,023.78
Eps
120.51
PE Ratio (TTM)
32.88
Dividend Yield
0.79
Industry
Healthcare
52 Week High
6,451.15
52 Week low
3,950.00
PB Ratio
5.40
Debt to Equity
0.01
Sector
Pharmaceuticals
Add Ratio
Live Chart

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
neutral
Pfizer: Diversity Fellowship Program Revised After Legal Challenge4 days ago
Pfizer has resolved a lawsuit by conservative group Do No Harm, which alleged discrimination in its diversity fellowship program. The company will stop accepting new fellows and has opened the program to all applicants regardless of race. This settlement follows a recent appeals court decision that revived the case.
negative
Pfizer Reports Decline in Q3 EBITDA and Margin5 days ago
Pfizer's Q3 EBITDA decreased to 1.4 billion rupees from 1.52 billion rupees year-over-year. The company's EBITDA margin also declined to 26.77% from 28.25% compared to the same period last year.
neutral
Pfizer Reports Q3 Financial Results5 days ago
Pfizer announced its Q3 financial results. The company reported a net profit of 1.27 billion rupees, compared to 1.3 billion rupees year-over-year and 1.6 billion rupees quarter-over-quarter. Revenue for Q3 remained stable at 5.4 billion rupees, unchanged from the same period last year.
Growth Rate
Revenue Growth
-6.02 %
Net Income Growth
-11.64 %
Cash Flow Change
-27.79 %
ROE
-21.18 %
ROCE
-17.45 %
EBITDA Margin (Avg.)
-4.58 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
1,921
2,103
2,067
2,083
2,249
2,336
2,320
2,674
2,526
2,374
2,439
Expenses
1,470
1,586
1,617
1,468
1,516
1,579
1,526
1,775
1,616
1,558
1,534
EBITDA
450
517
450
615
733
757
793
898
910
816
905
Operating Profit %
21 %
21 %
18 %
25 %
27 %
27 %
32 %
32 %
33 %
29 %
31 %
Depreciation
131
124
63
66
71
103
109
115
106
62
58
Interest
1
1
1
0
1
11
15
11
13
15
13
Profit Before Tax
238
402
517
548
660
643
669
773
824
746
834
Tax
138
179
180
188
231
133
171
160
200
195
214
Net Profit
100
223
337
360
429
509
498
613
624
551
616
EPS in ₹
15.26
66.66
73.61
78.70
93.78
111.28
108.77
133.89
136.38
120.51
134.50
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
2,612
2,914
3,261
3,690
3,940
4,405
3,266
3,901
4,001
4,229
Fixed Assets
944
895
902
950
886
973
894
869
749
713
Current Assets
1,253
1,630
2,051
2,417
2,715
3,048
1,925
2,397
2,493
2,738
Capital Work in Progress
13
3
15
1
0
1
3
1
8
0
Investments
0
4
0
0
0
0
0
0
0
0
Other Assets
1,655
2,011
2,343
2,739
3,054
3,432
2,369
3,030
3,244
3,516
Total Liabilities
2,612
2,914
3,261
3,690
3,940
4,405
3,266
3,901
4,001
4,229
Current Liabilities
606
759
780
954
892
873
774
853
657
547
Non Current Liabilities
32
36
62
52
37
137
99
183
136
87
Total Equity
1,973
2,118
2,419
2,683
3,011
3,396
2,393
2,864
3,207
3,596
Reserve & Surplus
1,927
2,072
2,373
2,637
2,966
3,350
2,347
2,819
3,162
3,550
Share Capital
46
46
46
46
46
46
46
46
46
46
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
181
-417
-4
-17
23
1,690
-1,613
-88
-26
75
Investing Activities
68
-701
-250
-238
35
1,530
-469
-575
-36
54
Operating Activities
114
346
329
332
98
323
427
667
356
257
Financing Activities
-1
-62
-83
-110
-110
-164
-1,571
-181
-346
-235
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
63.92 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.82 %
0.00 %
3.33 %
3.22 %
3.54 %
2.75 %
DIIs
13.08 %
8.98 %
8.98 %
8.84 %
8.57 %
7.91 %
14.85 %
14.93 %
14.89 %
14.89 %
15.01 %
15.15 %
15.33 %
15.84 %
16.03 %
16.79 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
15.03 %
14.11 %
14.11 %
14.25 %
14.19 %
14.08 %
13.94 %
13.71 %
13.70 %
13.69 %
13.61 %
13.21 %
12.90 %
12.55 %
12.15 %
12.12 %
No of Share Holders
1,45,980
1,21,153
1,21,153
1,26,808
1,25,287
1,23,449
1,22,028
1,17,950
1,17,194
1,15,988
1,16,948
1,12,456
1,09,214
1,06,098
98,824
1,05,015

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Announcements

Receipt Of GST Order Levying Tax Demand And Penalty
2 hours ago
Receipt Of GST Order Levying Tax Demand And Penalty
9 hours ago
Receipt Of GST Order For A Tax Demand Interest And Penalty
1 day ago
View more

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,752.75 4,20,543.44 35.94 49,887.20 12.06 9,648 13.77 44.79
Divis Laboratories
6,123.50 1,62,559.68 78.25 8,184.00 0.89 1,600 64.53 60.08
Cipla
1,436.80 1,16,037.99 23.45 26,520.70 14.17 4,155 47.38 46.67
Torrent Pharmaceuticals
3,114.70 1,05,415.60 56.43 10,785.70 11.59 1,656 13.54 35.94
Mankind Pharma
2,483.00 1,02,440.36 51.56 10,615.60 19.57 1,942 -16.38 42.73
Dr Reddys Laboratories
1,227.55 1,02,428.11 18.95 28,905.40 12.36 5,578 1.69 41.25
Lupin
2,185.10 99,683.73 36.66 20,141.50 19.94 1,936 73.53 56.12
Zydus Life Science
977.00 98,309.06 22.90 19,831.50 13.82 3,831 29.92 51.89
Aurobindo Pharma
1,191.75 69,217.03 18.82 29,559.20 17.55 3,169 8.66 48.98
Alkem Laboratories
5,117.95 61,192.77 28.08 12,978.40 9.84 1,812 14.16 43.89

Corporate Action

Technical Indicators

RSI(14)
Neutral
29.09
ATR(14)
Less Volatile
149.49
STOCH(9,6)
Neutral
21.37
STOCH RSI(14)
Neutral
33.70
MACD(12,26)
Bearish
-24.81
ADX(14)
Strong Trend
28.84
UO(9)
Bearish
50.09
ROC(12)
Downtrend And Accelerating
-10.49
WillR(14)
Oversold
-88.46
Bearish
3
Neutral
5
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Fundamental Screeners
Candlestick Screeners
Technical Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.